Treatment with liraglutide, metformin, or their combination significantly decreased GLP-1R protein expression when compared to the untreated T1DM group (Figure 2C), suggesting that AMPK could be a potential regulator of GLP-1R in diabetes. This evidence concerns the gene GLP1R and diabetes mellitus.